These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12096007)

  • 1. Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate.
    Kobayashi T; Tateda K; Matsumoto T; Miyazaki S; Watanabe A; Nukiwa T; Yamaguchi K
    J Antimicrob Chemother; 2002 Jul; 50(1):59-66. PubMed ID: 12096007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.
    Schultz MJ; Rijneveld AW; Florquin S; Speelman P; VAN Deventer SJH; VAN DER Poll T
    J Med Microbiol; 2001 Sep; 50(9):822-827. PubMed ID: 11549184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
    Tateda K; Ishii Y; Matsumoto T; Kobayashi T; Miyazaki S; Yamaguchi K
    J Infect Chemother; 2000 Mar; 6(1):1-7. PubMed ID: 11810524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous tumor necrosis factor (TNF) alpha mediates neutrophil accumulation at the mid-phase of a murine model of Pseudomonas aeruginosa pneumonia.
    Sonoda F; Oishi K; Iwagaki A; Matsumoto K
    Microbiol Immunol; 1997; 41(8):601-8. PubMed ID: 9310939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa.
    Schultz MJ; Knapp S; Florquin S; Pater J; Takeda K; Akira S; van der Poll T
    Infect Immun; 2003 Apr; 71(4):1630-4. PubMed ID: 12654774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
    Oshima K; Nakamura S; Iwanaga N; Takemoto K; Miyazaki T; Yanagihara K; Miyazaki Y; Mukae H; Kohno S; Izumikawa K
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
    Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
    J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia.
    Schultz MJ; Rijneveld AW; Speelman P; van Deventer SJ; van der Poll T
    Eur Cytokine Netw; 2001 Mar; 12(1):39-44. PubMed ID: 11282544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.
    Molinari G; Guzmán CA; Pesce A; Schito GC
    J Antimicrob Chemother; 1993 May; 31(5):681-8. PubMed ID: 8392997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.
    Kimura S; Mori N; Kai T; Ishii Y; Yamaguchi K; Tateda K
    J Infect Chemother; 2017 Aug; 23(8):550-555. PubMed ID: 28579350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice.
    Liu J; Feng Y; Yang K; Li Q; Ye L; Han L; Wan H
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):179-88. PubMed ID: 21204996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
    Mueller-Ortiz SL; Drouin SM; Wetsel RA
    Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.
    Kikuchi Y; Tateda K; Fuse ET; Matsumoto T; Gotoh N; Fukushima J; Takizawa H; Nagase T; Standiford TJ; Yamaguchi K
    Pulm Pharmacol Ther; 2009 Aug; 22(4):333-9. PubMed ID: 19162211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
    Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
    Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.
    Wölbeling F; Munder A; Kerber-Momot T; Neumann D; Hennig C; Hansen G; Tümmler B; Baumann U
    Immunobiology; 2011 Aug; 216(8):901-8. PubMed ID: 21497410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
    Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
    Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor-2 inhibits bacterial infection with Pseudomonas aeruginosa pneumonia in a mouse model.
    Feng N; Wang Q; Zhou J; Li J; Wen X; Chen S; Zhu Z; Bai C; Song Y; Li H
    J Infect Chemother; 2016 Jan; 22(1):44-52. PubMed ID: 26617350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.
    Bui KQ; Banevicius MA; Nightingale CH; Quintiliani R; Nicolau DP
    J Antimicrob Chemother; 2000 Jan; 45(1):57-62. PubMed ID: 10629013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.